Advertisement

Topics

Investigative drug for dwarfism gains orphan status

10:56 EDT 22 Jun 2017 | SmartBrief

Therachon's TA-46 to treat achondroplasia gained orphan drug status from the FDA and the European Medicines Agency.  -More

Original Article: Investigative drug for dwarfism gains orphan status

NEXT ARTICLE

More From BioPortfolio on "Investigative drug for dwarfism gains orphan status"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...